Biotech IPO boom has arrived in Europe

Biotech IPO boom has arrived in Europe

2014 was a record year for biotech companies on the European stock market, with a total of €2.4bn raised in the year – 25% more than in the year before.

The European biotech industry experienced a stock market boom in 2014. A total of €2.4bn was poured into biotech companies in Europe via the stock exchange, an increase of 25% compared to the previous year (2013: €1.9bn).

The number of biotech IPOs tripled to 15. A total of 150 biotech companies with a market capitalisation of €66bn are now listed on the 15 most important stock exchanges in Europe.

Read more.


ScanBalt members: